Characterization and toxicity of citral incorporated with nanostructured lipid carrier

The nanoparticle as a cancer drug delivery vehicle is rapidly under investigation due to its promising applicability as a novel drug delivery system for anticancer agents. This study describes the development, characterization and toxicity studies of a nanostructured lipid carrier (NLC) system for c...

Full description

Bibliographic Details
Main Authors: Noraini Nordin, Swee Keong Yeap, Nur Rizi Zamberi, Nadiah Abu, Nurul Elyani Mohamad, Heshu Sulaiman Rahman, Chee Wun How, Mas Jaffri Masarudin, Rasedee Abdullah, Noorjahan Banu Alitheen
Format: Article
Language:English
Published: PeerJ Inc. 2018-01-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/3916.pdf
id doaj-8e0abb72673941b7a1171d84b9a26087
record_format Article
spelling doaj-8e0abb72673941b7a1171d84b9a260872020-11-24T23:00:51ZengPeerJ Inc.PeerJ2167-83592018-01-016e391610.7717/peerj.3916Characterization and toxicity of citral incorporated with nanostructured lipid carrierNoraini Nordin0Swee Keong Yeap1Nur Rizi Zamberi2Nadiah Abu3Nurul Elyani Mohamad4Heshu Sulaiman Rahman5Chee Wun How6Mas Jaffri Masarudin7Rasedee Abdullah8Noorjahan Banu Alitheen9Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor, MalaysiaChina-ASEAN College of Marine Sciences, Xiamen University Malaysia, Sepang, MalaysiaDepartment of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor, MalaysiaDepartment of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor, MalaysiaDepartment of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor, MalaysiaDepartment of Microbiology, Faculty of Veterinary Medicine, University of Sulaimanyah, Sulaimanyah, Kurdistan Region, IraqInstitute of Bioscience, Universiti Putra Malaysia, Serdang, Selangor, MalaysiaDepartment of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor, MalaysiaInstitute of Bioscience, Universiti Putra Malaysia, Serdang, Selangor, MalaysiaDepartment of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Selangor, MalaysiaThe nanoparticle as a cancer drug delivery vehicle is rapidly under investigation due to its promising applicability as a novel drug delivery system for anticancer agents. This study describes the development, characterization and toxicity studies of a nanostructured lipid carrier (NLC) system for citral. Citral was loaded into the NLC using high pressure homogenization methods. The characterizations of NLC-citral were then determined through various methods. Based on Transmission Electron Microscope (TEM) analysis, NLC-Citral showed a spherical shape with an average diameter size of 54.12 ± 0.30 nm and a polydipersity index of 0.224 ± 0.005. The zeta potential of NLC-Citral was −12.73 ± 0.34 mV with an entrapment efficiency of 98.9 ± 0.124%, and drug loading of 9.84 ± 0.041%. Safety profile of the formulation was examined via in vitro and in vivo routes to study its effects toward normal cells. NLC-Citral exhibited no toxic effects towards the proliferation of mice splenocytes. Moreover, no mortality and toxic signs were observed in the treated groups after 28 days of treatment. There were also no significant alterations in serum biochemical analysis for all treatments. Increase in immunomodulatory effects of treated NLC-Citral and Citral groups was verified from the increase in CD4/CD3 and CD8/CD3 T cell population in both NLC-citral and citral treated splenocytes. This study suggests that NLC is a promising drug delivery system for citral as it has the potential in sustaining drug release without inducing any toxicity.https://peerj.com/articles/3916.pdfNanostructured lipid carrierCitralToxicityCharacterization
collection DOAJ
language English
format Article
sources DOAJ
author Noraini Nordin
Swee Keong Yeap
Nur Rizi Zamberi
Nadiah Abu
Nurul Elyani Mohamad
Heshu Sulaiman Rahman
Chee Wun How
Mas Jaffri Masarudin
Rasedee Abdullah
Noorjahan Banu Alitheen
spellingShingle Noraini Nordin
Swee Keong Yeap
Nur Rizi Zamberi
Nadiah Abu
Nurul Elyani Mohamad
Heshu Sulaiman Rahman
Chee Wun How
Mas Jaffri Masarudin
Rasedee Abdullah
Noorjahan Banu Alitheen
Characterization and toxicity of citral incorporated with nanostructured lipid carrier
PeerJ
Nanostructured lipid carrier
Citral
Toxicity
Characterization
author_facet Noraini Nordin
Swee Keong Yeap
Nur Rizi Zamberi
Nadiah Abu
Nurul Elyani Mohamad
Heshu Sulaiman Rahman
Chee Wun How
Mas Jaffri Masarudin
Rasedee Abdullah
Noorjahan Banu Alitheen
author_sort Noraini Nordin
title Characterization and toxicity of citral incorporated with nanostructured lipid carrier
title_short Characterization and toxicity of citral incorporated with nanostructured lipid carrier
title_full Characterization and toxicity of citral incorporated with nanostructured lipid carrier
title_fullStr Characterization and toxicity of citral incorporated with nanostructured lipid carrier
title_full_unstemmed Characterization and toxicity of citral incorporated with nanostructured lipid carrier
title_sort characterization and toxicity of citral incorporated with nanostructured lipid carrier
publisher PeerJ Inc.
series PeerJ
issn 2167-8359
publishDate 2018-01-01
description The nanoparticle as a cancer drug delivery vehicle is rapidly under investigation due to its promising applicability as a novel drug delivery system for anticancer agents. This study describes the development, characterization and toxicity studies of a nanostructured lipid carrier (NLC) system for citral. Citral was loaded into the NLC using high pressure homogenization methods. The characterizations of NLC-citral were then determined through various methods. Based on Transmission Electron Microscope (TEM) analysis, NLC-Citral showed a spherical shape with an average diameter size of 54.12 ± 0.30 nm and a polydipersity index of 0.224 ± 0.005. The zeta potential of NLC-Citral was −12.73 ± 0.34 mV with an entrapment efficiency of 98.9 ± 0.124%, and drug loading of 9.84 ± 0.041%. Safety profile of the formulation was examined via in vitro and in vivo routes to study its effects toward normal cells. NLC-Citral exhibited no toxic effects towards the proliferation of mice splenocytes. Moreover, no mortality and toxic signs were observed in the treated groups after 28 days of treatment. There were also no significant alterations in serum biochemical analysis for all treatments. Increase in immunomodulatory effects of treated NLC-Citral and Citral groups was verified from the increase in CD4/CD3 and CD8/CD3 T cell population in both NLC-citral and citral treated splenocytes. This study suggests that NLC is a promising drug delivery system for citral as it has the potential in sustaining drug release without inducing any toxicity.
topic Nanostructured lipid carrier
Citral
Toxicity
Characterization
url https://peerj.com/articles/3916.pdf
work_keys_str_mv AT noraininordin characterizationandtoxicityofcitralincorporatedwithnanostructuredlipidcarrier
AT sweekeongyeap characterizationandtoxicityofcitralincorporatedwithnanostructuredlipidcarrier
AT nurrizizamberi characterizationandtoxicityofcitralincorporatedwithnanostructuredlipidcarrier
AT nadiahabu characterizationandtoxicityofcitralincorporatedwithnanostructuredlipidcarrier
AT nurulelyanimohamad characterizationandtoxicityofcitralincorporatedwithnanostructuredlipidcarrier
AT heshusulaimanrahman characterizationandtoxicityofcitralincorporatedwithnanostructuredlipidcarrier
AT cheewunhow characterizationandtoxicityofcitralincorporatedwithnanostructuredlipidcarrier
AT masjaffrimasarudin characterizationandtoxicityofcitralincorporatedwithnanostructuredlipidcarrier
AT rasedeeabdullah characterizationandtoxicityofcitralincorporatedwithnanostructuredlipidcarrier
AT noorjahanbanualitheen characterizationandtoxicityofcitralincorporatedwithnanostructuredlipidcarrier
_version_ 1725641111944298496